Envoy Medical (COCHW) Cash from Operations (2021 - 2026)

Envoy Medical has disclosed Cash from Operations across 6 years of filings, most recently posting 6061000.0 for Q1 2026.

• Cash from Operations for Q1 2026 came in at 6061000.0, down 62.71% year-over-year; the trailing twelve-month figure through Mar 2026 was 20537000.0 (down 27.68% YoY), and the FY2025 annual result was 18201000.0, down 1.4% from the prior year.
• Cash from Operations came in at 6061000.0 for Q1 2026 at Envoy Medical, down from 5685000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 1099000.0 in Q3 2023 to a low of 11145000.0 in Q4 2023.
• The 5-year median for Cash from Operations is 4331000.0 (2025), against an average of 4006294.12.
• Peak annual rise in Cash from Operations reached 120.92% in 2023, while the deepest fall reached 908.1% in 2023.
• Envoy Medical's Cash from Operations stood at 2379000.0 in 2022, then slumped by 368.47% to 11145000.0 in 2023, then surged by 54.32% to 5091000.0 in 2024, then slipped by 11.67% to 5685000.0 in 2025, then fell by 6.61% to 6061000.0 in 2026.
• The last three Cash from Operations figures came in at 6061000.0 (Q1 2026), 5685000.0 (Q4 2025), and 4331000.0 (Q3 2025), per Business Quant data.